Evelyn Ting

405 total citations
14 papers, 331 citations indexed

About

Evelyn Ting is a scholar working on Cancer Research, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Evelyn Ting has authored 14 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Molecular Biology and 3 papers in Otorhinolaryngology. Recurrent topics in Evelyn Ting's work include Breast Cancer Treatment Studies (5 papers), Head and Neck Cancer Studies (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Evelyn Ting is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Head and Neck Cancer Studies (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Evelyn Ting collaborates with scholars based in Germany, Switzerland and United States. Evelyn Ting's co-authors include Svjetlana Mohrmann, Christopher Poremba, Oleg Gluz, Ulrike Nitz, Alexander Herr, Peter J. Wild, Arndt Hartmann, Ronald Kates, Nadia Harbeck and Christian Jackisch and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Evelyn Ting

14 papers receiving 322 citations

Peers

Evelyn Ting
Alba Mota Spain
Susanne Beck Germany
Brian C. Willis United States
Thomas S. DeNapoli United States
Figlin Ra United States
Maria Farooq United States
Alba Mota Spain
Evelyn Ting
Citations per year, relative to Evelyn Ting Evelyn Ting (= 1×) peers Alba Mota

Countries citing papers authored by Evelyn Ting

Since Specialization
Citations

This map shows the geographic impact of Evelyn Ting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evelyn Ting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evelyn Ting more than expected).

Fields of papers citing papers by Evelyn Ting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evelyn Ting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evelyn Ting. The network helps show where Evelyn Ting may publish in the future.

Co-authorship network of co-authors of Evelyn Ting

This figure shows the co-authorship network connecting the top 25 collaborators of Evelyn Ting. A scholar is included among the top collaborators of Evelyn Ting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evelyn Ting. Evelyn Ting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Latus, Joerg, Jonas Schmidt‐Chanasit, Klara Tenner‐Racz, et al.. (2011). Hantavirus and acute appendicitis—The diagnosis behind the diagnosis?. Journal of Clinical Virology. 53(2). 156–158. 8 indexed citations
2.
Gluz, Oleg, Peter J. Wild, Cornelia Liedtke, et al.. (2011). Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial. Breast Cancer Research and Treatment. 126(3). 643–651. 6 indexed citations
3.
Latus, Joerg, et al.. (2011). Early Stages of Calciphylaxis: Are Skin Biopsies the Answer. SHILAP Revista de lepidopterología. 3(3). 201–205. 23 indexed citations
4.
Gluz, Oleg, Karin Mengele, Manfred Schmitt, et al.. (2009). Y-Box–Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy. Journal of Clinical Oncology. 27(36). 6144–6151. 39 indexed citations
5.
Gluz, Oleg, Peter J. Wild, Evelyn Ting, et al.. (2008). Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity. International Journal of Cancer. 123(6). 1433–1438. 66 indexed citations
6.
Gluz, Oleg, Ulrike Nitz, Nadia Harbeck, et al.. (2008). Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial. Annals of Oncology. 19(5). 861–870. 84 indexed citations
7.
Ting, Evelyn, Oleg Gluz, Alexander Herr, et al.. (2007). Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy. Clinical Cancer Research. 13(2). 488–497. 57 indexed citations
8.
Marini, Alessandra, Martin Wagenmann, Evelyn Ting, & Ulrich R. Hengge. (2007). Squamous Cell Cancer and Human Papillomavirus Infection in Oral Lichen Planus: Case Report and Literature Review. Dermatologic Surgery. 33(6). 756–760. 8 indexed citations
9.
Marini, Alessandra, Martin Wagenmann, Evelyn Ting, & Ulrich R. Hengge. (2007). Squamous Cell Cancer and Human Papillomavirus Infection in Oral Lichen Planus. Dermatologic Surgery. 33(6). 756–760. 1 indexed citations
10.
Ting, Evelyn, et al.. (2007). [Prognostic and predictive impact of protein expression profiling in high risk breast cancer patients treated with high-dose chemotherapy].. PubMed. 91. 187–96. 1 indexed citations
11.
Diallo, Raihanatou, Achim Rody, Christian Jackisch, et al.. (2006). C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu. Human Pathology. 37(2). 205–211. 20 indexed citations
12.
Diallo, Raihanatou, Evelyn Ting, Oleg Gluz, et al.. (2006). C-kit expression in high-risk breast cancer subgroup treated with high-dose or conventional dose-dense chemotherapy.. PubMed. 90. 177–85. 7 indexed citations
13.
Herr, Alexander, Oleg Gluz, Evelyn Ting, et al.. (2006). Biological characteristics in triple negative high risk breast cancer and their clinical implications. Journal of Clinical Oncology. 24(18_suppl). 20032–20032. 5 indexed citations
14.
Gluz, Oleg, Alexander Herr, Evelyn Ting, et al.. (2006). Retrospective analysis of WSG AM01 tandem high dose chemotherapy trial in high risk primary breast cancer: A hypothesis generating study. Journal of Clinical Oncology. 24(18_suppl). 665–665. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026